Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension.

Clinical lymphoma, myeloma & leukemia - 1 Jan 2015

Yan Matthew, Geyer Holly, Mesa Ruben, Atallah Ehab, Callum Jeannie, Bartoszko Justyna, Yee Karen, Maganti Manjula, Wong Florence, Gupta Vikas

Abstract excerpt

BACKGROUND: Portal hypertension has been reported to afflict 7% to 18% of patients with Philadelphia-negative MPNs, with complications of variceal bleeding and ascites. The clinical features and outcomes of these patients are unclear. PATIENTS AND METHODS: In this multicenter retrospective study, we evaluated the clinical features of 51 patients with MPNs complicated by PHTN. RESULTS: The diagnosis of underlying...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Follow-Up Studies
Share to Hypertension, Portal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Incidence

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Philadelphia Chromosome

Share to Protein Kinase Inhibitors

Share to Thrombosis

Source

Open in PubMed Open full text

Identifiers

PMID: 25027569
DOI: 10.1016/j.clml.2014.04.004
PMCID: PMC4361182

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension.PMID 25027569Read ↗

Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.Semantic proximity Read ↗

Splanchnic venous thrombosis driven by a constitutively activated JAK2 V617F philadelphia-negative myeloproliferative neoplasm: a case report.Semantic proximity Read ↗

Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.Semantic proximity Read ↗

Splenic Infarction in Patients with Philadelphia-negative Myeloproliferative Neoplasms.Semantic proximity Read ↗

The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective.Semantic proximity Read ↗

Thrombotic and bleeding complications in classical myeloproliferative neoplasms.Semantic proximity Read ↗

Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights.Semantic proximity Read ↗

Current approaches to challenging scenarios in myeloproliferative neoplasms.Semantic proximity Read ↗

Splanchnic vein thrombosis in myeloproliferative neoplasms.Semantic proximity Read ↗

Splanchnic Vein Thrombosis in Myelofibrosis-An Underappreciated Hallmark of Disease Phenotype.Semantic proximity Read ↗

[Clinical and epidemiological characteristics of the Philadelphia negative myeloproliferative neoplasms in Chile].Semantic proximity Read ↗

[Clinical and epidemiological characteristics of the Philadelphia negative myeloproliferative neoplasms in Chile].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.